+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2026-2032- Product Image
Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2026-2032- Product Image
Sale

Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148287
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mycobacterium Tuberculosis Test Kit Market is projected to reach USD 2.45 Billion in 2026. It is expected to continue growing at a CAGR of 5.93%, reaching USD 3.45 Billion by 2032.

Mycobacterium Tuberculosis Test Kits: Executive Summary

Mycobacterium tuberculosis test kits support the detection of tuberculosis (TB) infection and disease through molecular, immunological, microbiological, and other laboratory approaches. Their value is closely tied to timely diagnosis, drug-resistance identification, contact tracing, treatment initiation, and surveillance. Demand is shaped by TB burden, public-health screening policies, laboratory capacity, antimicrobial-resistance priorities, and access to quality-assured diagnostics.

Diagnostics Are Shifting Toward Faster, Decentralized Testing

TB testing is moving from exclusively centralized workflows toward combinations of reference laboratories, near-patient platforms, and integrated specimen-to-result systems. Molecular methods are increasingly important because they can detect M. tuberculosis and selected resistance markers more rapidly than conventional culture, while culture remains essential for confirmation and comprehensive susceptibility testing. Implementation challenges include specimen quality, contamination control, instrument maintenance, supply continuity, biosafety, result connectivity, and the need to link testing with treatment and public-health services.

Artificial Intelligence Strengthens Interpretation and Laboratory Operations

Artificial intelligence can augment TB screening and diagnosis by supporting interpretation of chest radiographs, prioritizing presumptive cases, identifying quality issues, and helping laboratories manage workflows. Its cumulative impact depends on representative training data, external validation, transparent performance assessment, and integration with confirmatory testing rather than use as an unsupported replacement for microbiological diagnosis. Responsible deployment also requires attention to bias, patient privacy, cybersecurity, human oversight, and clear pathways for communicating uncertain results.

Regional Insights: Uneven Burden Meets Expanding Diagnostic Capacity

North America emphasizes case finding, resistance testing, laboratory quality, and surveillance within comparatively mature health systems. Latin America is balancing persistent transmission and access gaps with expansion of molecular testing and stronger referral networks. Europe is prioritizing rapid diagnosis, migrant and vulnerable-population screening, antimicrobial resistance, and cross-border surveillance. The Middle East is shaped by displaced populations, workforce mobility, and uneven laboratory access, while Africa continues to face a high burden alongside major needs in decentralized testing, specimen transport, and treatment linkage. Asia-Pacific combines large and diverse TB programs, with substantial opportunities to expand community access, digital connectivity, and resistance detection.

Group Insights: Policy Blocks Shape Procurement and Implementation

ASEAN countries face varied burdens, health-system capacities, and cross-border mobility, making interoperable referral and surveillance systems valuable. BRICS members represent diverse epidemiological and laboratory settings, with a common need to strengthen resistance detection, domestic supply resilience, and equitable access. The European Union emphasizes harmonized standards, surveillance, and coordinated responses to mobile populations. G7 systems generally focus on innovation, quality assurance, preparedness, and support for global TB control. GCC countries place importance on screening mobile workforces and maintaining efficient referral pathways, while NATO members must also consider continuity of diagnostics during humanitarian emergencies, displacement, and health-system disruption.

Country Insights: Different Priorities Across Major TB Testing Markets

Australia emphasizes surveillance, targeted screening, and high-quality reference testing. Brazil continues to require broad access to rapid diagnosis and resistance assessment across diverse regions. Canada focuses on vulnerable populations, laboratory quality, and public-health coordination. China and India require scalable testing, case finding, and resistance detection across large and heterogeneous health systems. France, Germany, Italy, Spain, and the United Kingdom emphasize early diagnosis, migrant and risk-group services, antimicrobial resistance, and integrated surveillance. Japan and South Korea maintain strong laboratory and public-health capabilities while addressing aging populations and reactivation risk. Mexico continues to need accessible molecular testing, reliable specimen networks, and treatment linkage. Russia faces priorities around drug-resistant TB detection, laboratory quality, and continuity of care. The United States emphasizes targeted screening, rapid confirmation, resistance testing, and outbreak response.

Action Priorities for Leaders: Build Reliable, Connected Diagnostic Pathways

Industry leaders should align assay development with clinical and public-health use cases, including pulmonary and extrapulmonary disease, pediatric testing, and resistance detection. They should design for decentralized settings through robust instruments, minimal hands-on steps, clear quality controls, and dependable connectivity. Evidence generation should include diverse populations, challenging specimens, real-world workflow studies, and transparent comparisons with accepted reference methods. Partnerships with ministries, laboratories, clinicians, and community organizations can improve training, procurement, service contracts, and treatment linkage. Leaders should also establish responsible AI governance, strengthen supply-chain resilience, support local technical capacity, and measure performance through turnaround time, invalid-result rates, linkage to care, and equitable access.

Research Methodology: Evidence-Based Assessment of Diagnostic Priorities

This executive summary uses the defined market scope of Mycobacterium tuberculosis test kits and synthesizes established diagnostic, epidemiological, regulatory, laboratory, and public-health considerations. The assessment distinguishes molecular, culture-based, immunological, and related testing roles; considers workflow, infrastructure, quality, resistance detection, and access; and compares implications across the specified regions, country groups, and countries. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis. Findings should be validated against current guidance, national TB programs, regulatory decisions, and peer-reviewed evidence before operational or investment decisions.

Conclusion: Diagnostic Integration Is Central to Better TB Control

The strategic opportunity in Mycobacterium tuberculosis test kits is to make accurate, rapid, and actionable diagnosis more accessible across varied health systems. Molecular testing, culture, resistance assessment, digital connectivity, and carefully governed AI each have distinct roles. Sustainable progress will depend less on isolated technology adoption than on complete diagnostic pathways that connect specimen collection, laboratory quality, result interpretation, treatment initiation, surveillance, and patient support.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Mycobacterium Tuberculosis Test Kit Market, by Technology
7.1. Introduction
7.2. Culture Methods
7.2.1. Automated Culture Systems
7.2.2. Conventional Solid Medium Culture
7.3. Immunological Tests
7.3.1. Enzyme-Linked Immunosorbent Assay
7.3.2. Lateral Flow Assay
7.4. Microscopy Tests
7.4.1. Fluorescence Microscopy
7.4.2. Ziehl-Neelsen Staining
7.5. Molecular Tests
7.5.1. Cartridge-Based Nucleic Acid Amplification
7.5.2. Loop-Mediated Isothermal Amplification
7.5.3. Real-Time Polymerase Chain Reaction
8. Mycobacterium Tuberculosis Test Kit Market, by Application
8.1. Introduction
8.2. Diagnostic Testing
8.2.1. Active Tuberculosis Detection
8.2.1.1. Culture-Based Diagnostic Testing
8.2.1.2. Immunological Diagnostic Testing
8.2.1.3. Microscopy Diagnostic Testing
8.2.1.4. Molecular Diagnostic Testing
8.2.2. Latent Tuberculosis Infection Detection
8.2.2.1. Interferon Gamma Release Assay
8.2.2.2. Tuberculin Skin Test
8.3. Drug Susceptibility Testing
8.3.1. Genotypic Drug Susceptibility Testing
8.3.1.1. Cartridge-Based Assays
8.3.1.2. Line Probe Assay
8.3.1.3. Real-Time Polymerase Chain Reaction Assay
8.3.2. Phenotypic Drug Susceptibility Testing
8.3.2.1. Liquid Culture-Based Drug Susceptibility Testing
8.3.2.2. Solid Culture-Based Drug Susceptibility Testing
9. Mycobacterium Tuberculosis Test Kit Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Diagnostic Laboratories
9.4. Hospitals
9.5. Research Institutes
10. Mycobacterium Tuberculosis Test Kit Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Sales
10.4. Retail Pharmacies
11. Mycobacterium Tuberculosis Test Kit Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Mycobacterium Tuberculosis Test Kit Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Mycobacterium Tuberculosis Test Kit Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Becton, Dickinson and Company
15.3. Bio-Rad Laboratories, Inc.
15.4. bioMérieux SA
15.5. Cepheid, Inc.
15.6. Eiken Chemical Co., Ltd.
15.7. Hain Lifescience GmbH
15.8. Hologic, Inc.
15.9. Molbio Diagnostics Private Limited
15.10. Nipro Corporation
15.11. QIAGEN N.V.
15.12. Roche Diagnostics International Ltd.
15.13. SD Biosensor, Inc.
15.14. Serum Institute of India Pvt. Ltd.
15.15. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Mycobacterium Tuberculosis Test Kit Market, Years Considered for the Study
FIGURE 2. Global Mycobacterium Tuberculosis Test Kit Market, Research Design
FIGURE 3. Global Mycobacterium Tuberculosis Test Kit Market, Research Framework
FIGURE 4. Global Mycobacterium Tuberculosis Test Kit Market, Data Triangulation
FIGURE 5. Global Mycobacterium Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Mycobacterium Tuberculosis Test Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Mycobacterium Tuberculosis Test Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Mycobacterium Tuberculosis Test Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Mycobacterium Tuberculosis Test Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Mycobacterium Tuberculosis Test Kit Market Segmentation & Coverage
TABLE 2. Global Mycobacterium Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Culture Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Culture Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Culture Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Automated Culture Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Automated Culture Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Automated Culture Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Conventional Solid Medium Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Conventional Solid Medium Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Conventional Solid Medium Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Immunological Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Immunological Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Immunological Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Enzyme-Linked Immunosorbent Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Enzyme-Linked Immunosorbent Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Enzyme-Linked Immunosorbent Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Lateral Flow Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Lateral Flow Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Lateral Flow Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Microscopy Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Microscopy Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Microscopy Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Fluorescence Microscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Fluorescence Microscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Fluorescence Microscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Ziehl-Neelsen Staining Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Ziehl-Neelsen Staining Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Ziehl-Neelsen Staining Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Molecular Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Molecular Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Molecular Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Cartridge-Based Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Cartridge-Based Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Cartridge-Based Nucleic Acid Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Loop-Mediated Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Loop-Mediated Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Loop-Mediated Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Real-Time Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Real-Time Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Real-Time Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 44. Global Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Diagnostic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Active Tuberculosis Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Active Tuberculosis Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Active Tuberculosis Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Culture-Based Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Culture-Based Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Culture-Based Diagnostic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Immunological Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Immunological Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Immunological Diagnostic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Microscopy Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Microscopy Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Microscopy Diagnostic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Molecular Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Molecular Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Molecular Diagnostic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Latent Tuberculosis Infection Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Latent Tuberculosis Infection Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Latent Tuberculosis Infection Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Interferon Gamma Release Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Interferon Gamma Release Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Interferon Gamma Release Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Tuberculin Skin Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Tuberculin Skin Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Tuberculin Skin Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Drug Susceptibility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Drug Susceptibility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Drug Susceptibility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Genotypic Drug Susceptibility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Genotypic Drug Susceptibility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Genotypic Drug Susceptibility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Cartridge-Based Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Cartridge-Based Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Cartridge-Based Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Line Probe Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Line Probe Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Line Probe Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Real-Time Polymerase Chain Reaction Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Real-Time Polymerase Chain Reaction Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Real-Time Polymerase Chain Reaction Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Phenotypic Drug Susceptibility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Phenotypic Drug Susceptibility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Phenotypic Drug Susceptibility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Liquid Culture-Based Drug Susceptibility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Liquid Culture-Based Drug Susceptibility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Liquid Culture-Based Drug Susceptibility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Solid Culture-Based Drug Susceptibility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Solid Culture-Based Drug Susceptibility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Solid Culture-Based Drug Susceptibility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. North America Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. North America Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. North America Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 137. North America Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 138. North America Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 139. North America Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 140. North America Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. North America Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 142. North America Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 143. North America Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 144. North America Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 145. North America Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 146. North America Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 147. North America Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. North America Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 152. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 153. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 154. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 155. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 157. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 158. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 159. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 160. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 161. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 162. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Latin America Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 167. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 168. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 169. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 170. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 172. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 173. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 174. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 175. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 176. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 177. Europe Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Europe Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 182. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 183. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 184. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 185. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 187. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 188. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 189. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 190. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 191. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 192. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Middle East Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 197. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 198. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 199. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 200. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 202. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 203. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 204. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 205. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 206. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 207. Africa Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. Africa Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. Global Mycobacterium Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 212. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 213. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 214. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 215. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 216. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 218. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 219. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 220. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 221. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 222. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 223. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. ASEAN Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 225. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 227. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 228. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 229. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 230. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 231. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 233. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 234. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 235. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 236. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 237. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 238. GCC Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. GCC Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 241. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 243. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 244. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 245. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 246. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 248. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 249. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 250. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 251. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 252. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 253. European Union Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. European Union Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 258. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 259. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 260. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 261. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 263. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 264. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 265. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 266. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 267. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 268. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. BRICS Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 272. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 273. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 274. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 275. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 276. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 278. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 279. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 280. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 281. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 282. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 283. G7 Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. G7 Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 286. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 287. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Culture Methods, 2017-2032 (USD Million)
TABLE 288. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Immunological Tests, 2017-2032 (USD Million)
TABLE 289. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Microscopy Tests, 2017-2032 (USD Million)
TABLE 290. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Molecular Tests, 2017-2032 (USD Million)
TABLE 291. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Diagnostic Testing, 2017-2032 (USD Million)
TABLE 293. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Active Tuberculosis Detection, 2017-2032 (USD Million)
TABLE 294. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Latent Tuberculosis Infection Detection, 2017-2032 (USD Million)
TABLE 295. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 296. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Genotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 297. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Phenotypic Drug Susceptibility Testing, 2017-2032 (USD Million)
TABLE 298. NATO Mycobacterium Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. NATO Mycobacterium Tuberculosis Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 300. Global Mycobacterium Tuberculosis Test Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 301. United States Mycobacterium Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 302. United States Mycobacterium Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 303. United States Mycobacterium Tuberculosis Test Kit Market Size, by Culture Method

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Cepheid, Inc.
  • Eiken Chemical Co., Ltd.
  • Hain Lifescience GmbH
  • Hologic, Inc.
  • Molbio Diagnostics Private Limited
  • Nipro Corporation
  • QIAGEN N.V.
  • Roche Diagnostics International Ltd.
  • SD Biosensor, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Mycobacterium Tuberculosis Detection Kits Market - Global Forecast 2026-2032 - Product Image

Mycobacterium Tuberculosis Detection Kits Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market - Global Forecast 2026-2032 - Product Image

Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Mycobacterium Tuberculosis Market Report 2026 - Product Image

Mycobacterium Tuberculosis Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Mycobacterium Tuberculosis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

Mycobacterium Tuberculosis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • Global
From
Tuberculosis Diagnostics Market Size, Share, Trends and Forecast by Disease Stage, Test Type, End-User, and Region, 2026-2034 - Product Image

Tuberculosis Diagnostics Market Size, Share, Trends and Forecast by Disease Stage, Test Type, End-User, and Region, 2026-2034

  • Report
  • 137 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.